John W. Higuchi insider trades
Open-market stock purchases and sales by John W. Higuchi, Director at Lipocine Inc, from SEC Form 4 filings since Jun 16, 2015.
Track record: 0% of 6 scored buys are up 5% or more since purchase, averaging -41%.
Companies traded
- LPCN Lipocine Inc: 7 buys, 2 sales, last Sep 30, 2026